Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Immunoglobulin G glycosylation profiles in patients with influenza and bacterial pneumonia (CROSBI ID 684417)

Neobjavljeno sudjelovanje sa skupa | neobjavljeni prilog sa skupa | međunarodna recenzija

Kljakovic-Gaspic Batinjan, Marina ; Civljak, Rok ; Markotic, Alemka ; Lauc, Gordan ; Huljev, Eva Immunoglobulin G glycosylation profiles in patients with influenza and bacterial pneumonia // European Congress of Clinical Microbiology and Infectious Diseases Amsterdam, Nizozemska, 13.04.2019-16.04.2019

Podaci o odgovornosti

Kljakovic-Gaspic Batinjan, Marina ; Civljak, Rok ; Markotic, Alemka ; Lauc, Gordan ; Huljev, Eva

engleski

Immunoglobulin G glycosylation profiles in patients with influenza and bacterial pneumonia

Background: Acute respiratory tract infections, especially influenza and bacterial pneumonia, are among the leading causes of morbidity and mortality. Immunoglobulin G (IgG) plays an important role in protecting the human organism from pathogens and is an example of glycoprotein whose function is regulated by glycosylation. The aim of the study was to compare glycosylation profiles of IgG in patients with influenza and bacterial pneumonia. Materials/methods: A survey was conducted in adult patients hospitalized at the University Hospital for Infectious Diseases, Zagreb, due to acute respiratory tract infection. On three occasions (1st, 7th and 28th day after admission), the Hydrophilic Interaction Liquid Chromatography-Ultra High Performance Liquid Chromatography (HILIC-UHPLC) method was used to determine the glycosylation profile of IgG in the serum of all subjects. The results were compared with the glycosylation profile of 35 controls, which were matched by age and sex. We used a linear mixed model to analyze N- glycoprotein changes in time. We analyzed each of the 3 groups individually. P values were corrected for multiple assays using the Benjamini-Hochberg method. Results: The study included 36 adult patients, of whom 13 had influenza, and 23 bacterial pneumonia. Regarding galactose, in influenza the IgG glycome is changed toward more anti- inflammatory IgG activity ; there are a statistically significant decrease of agalactosylated structures (p < 0, 05) which are repeatedly associated with inflammation and an increase of sialylated moieties (p < 0, 01) associated with IgG anti-inflammation activity. Contrary, in pneumonia digalactosylated structures decrease (p < 0, 02) thus promoting IgG pro-inflammatory activity and acting contrary to the observed changes in influenza. Regarding bisecting N-acetylglucosamine (GlcNAc), a statistically significant decrease (p < 0.001) is observed in pneumonia which leads to enhanced anti-inflammatory activity of IgG and is in opposite to decreased digalactosylation, while bisecting GlcNAc remains unchanged in influenza. Conclusions: Differences in IgG glycome isolated from patients with influenza and pneumonia clearly indicate that IgG glycosylation is affected by distinct molecular pathways underlying the diseases. IgG glycosylation in influenza and bacterial pneumonia patients differs from the glycosylation profile of healthy subjects. Determination of the glycosylation profile of IgG could have a diagnostic and prognostic value.

influenza, bacterial pneumonia, glycosylation, immunoglobulin G

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

nije evidentirano

nije evidentirano

Podaci o skupu

European Congress of Clinical Microbiology and Infectious Diseases

poster

13.04.2019-16.04.2019

Amsterdam, Nizozemska

Povezanost rada

nije evidentirano